• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Bullish Friday For Marijuana Stocks - ESCO Technologies, Maple Leaf Green World Among Top Gainers

    2/16/24 4:30:05 PM ET
    $CGC
    $CRON
    $ESE
    $NEPT
    Medicinal Chemicals and Botanical Products
    Health Care
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $CGC alert in real time by email

    GAINERS:

    • ESCO Technologies (NYSE:ESE) shares closed up 110173.68% at $104.76
    • Maple Leaf Green World (OTC:MGWFF) shares closed up 164.46% at $0.03
    • Global Hemp Group (OTC:GBHPF) shares closed up 45.91% at $0.03
    • Target Group (OTC:CBDY) shares closed up 33.33% at $0.00
    • Global Compliance (OTC:FUAPF) shares closed up 30.43% at $0.01
    • Item 9 Labs (OTC:INLB) shares closed up 28.57% at $0.00045
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed up 20.00% at $0.01
    • Rocky Mountain High (OTC:RMHB) shares closed up 7.14% at $0.00
    • Neptune Wellness Solns (NASDAQ:NEPT) shares closed up 7.14% at $0.38
    • OrganiGram Holdings (NASDAQ:OGI) shares closed up 6.97% at $2.15
    • Pharmadrug (OTC:LMLLF) shares closed up 6.83% at $0.04
    • Cannabix Technologies (OTC:BLOZF) shares closed up 6.60% at $0.16
    • Canopy Gwth (NASDAQ:CGC) shares closed up 5.85% at $3.80
    • Cipher Pharmaceuticals (OTC:CPHRF) shares closed up 5.39% at $5.67
    • 4Front Ventures (OTC:FFNTF) shares closed up 5.29% at $0.09
    • 1933 Industries (OTC:TGIFF) shares closed up 4.04% at $0.01
    • Cronos Group (NASDAQ:CRON) shares closed up 3.18% at $2.27

    LOSERS:

    • Khiron Life Sciences (OTC:KHRNF) shares closed down 99.99% at $0.00
    • Choom Holdings (OTC:CHOOF) shares closed down 99.00% at $0.00
    • AusCann Group Holdings (OTC:ACNNF) shares closed down 47.54% at $0.00
    • Affinor Growers (OTC:RSSFF) shares closed down 20.00% at $0.06
    • SOL Glb Inv (OTC:SOLCF) shares closed down 10.16% at $0.07
    • RIV Capital (OTC:CNPOF) shares closed down 8.27% at $0.09
    • Zoned Props (OTC:ZDPY) shares closed down 7.58% at $0.46
    • Cresco Labs (OTC:CRLBF) shares closed down 6.34% at $1.73
    • iAnthus Capital Hldgs (OTC:ITHUF) shares closed down 5.00% at $0.02
    • CLS Holdings USA (OTC:CLSH) shares closed down 4.32% at $0.04
    • Body and Mind (OTC:BMMJ) shares closed down 3.89% at $0.08
    • EnWave (OTC:NWVCF) shares closed down 3.63% at $0.22
    • C21 Investments (OTC:CXXIF) shares closed down 3.33% at $0.40
    • Scotts Miracle Gro (NYSE:SMG) shares closed down 3.21% at $57.81

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $CGC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CGC
    $CRON
    $ESE
    $NEPT

    CompanyDatePrice TargetRatingAnalyst
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Cronos Group Inc.
    $CRON
    1/27/2026Buy
    Canaccord Genuity
    Canopy Growth Corporation
    $CGC
    11/10/2025Sell → Hold
    The Benchmark Company
    Scotts Miracle-Gro Company
    $SMG
    11/6/2025$70.00Hold → Buy
    Stifel
    Scotts Miracle-Gro Company
    $SMG
    6/9/2025$71.00Buy → Hold
    Stifel
    Scotts Miracle-Gro Company
    $SMG
    4/7/2025$69.00Hold → Buy
    Jefferies
    Scotts Miracle-Gro Company
    $SMG
    4/2/2025$70.00Hold → Buy
    Truist
    Scotts Miracle-Gro Company
    $SMG
    3/4/2025$78.00 → $70.00Hold → Buy
    Stifel
    More analyst ratings

    $CGC
    $CRON
    $ESE
    $NEPT
    SEC Filings

    View All

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    3/3/26 12:23:16 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Cronos Group Inc.

    10-K - Cronos Group Inc. (0001656472) (Filer)

    2/26/26 7:38:28 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Cronos Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Cronos Group Inc. (0001656472) (Filer)

    2/26/26 7:36:54 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $CGC
    $CRON
    $ESE
    $NEPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by EVP, CFO & CAO Scheiwer Mark J

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    3/2/26 11:21:34 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Chairman & CEO Hagedorn James

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    3/2/26 11:15:41 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    New insider Kenost Jared Matthew claimed ownership of 29,388 shares (SEC Form 3)

    3 - Cronos Group Inc. (0001656472) (Issuer)

    2/26/26 5:30:45 PM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $CGC
    $CRON
    $ESE
    $NEPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO & CAO Scheiwer Mark J bought $49,504 worth of shares (693 units at $71.44), increasing direct ownership by 5% to 15,370 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    2/25/26 11:29:13 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    Chief Executive Officer Mongeau Luc bought $49,994 worth of shares (27,469 units at $1.82), increasing direct ownership by 3% to 812,368 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    9/23/25 4:15:11 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    EVP, CFO & CAO Scheiwer Mark J bought $109,763 worth of shares (1,790 units at $61.32), increasing direct ownership by 21% to 10,130 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    9/4/25 11:22:10 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    $CGC
    $CRON
    $ESE
    $NEPT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia

    Launch aligns with rising Australian demand for alternatives to flower and strengthens Organigram's global medical cannabis presence Organigram Global Inc. ("Organigram" or the "Company") today announced the expansion of its international product portfolio, with the launch of Edison and BOXHOT medical cannabis vape and pastille products in Australia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224218487/en/ Australia has become one of the world's most dynamic medical cannabis markets, with increasing approvals for access and prescribers utilising a broader range of dosage forms1. While flower remains a core category, alt

    2/24/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group

    Organigram shares priced at average C$2.72 per share representing a combination of Top-Up Rights being exercised at C$2.34/share and shares issued in connection with Sanity acquisition priced at C$3.00/share. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading global cannabis company, today announced that it has entered into a subscription agreement (the "Subscription Agreement") with BT DE Investments Inc. ( "BAT"), a wholly-owned subsidiary of British American Tobacco p.l.c. (NYSE:BTI), in connection with its previously announced proposed acquisition (the "Acquisition") of Sanity Group GmbH ("Sanity" or "Sanity Group"), including shares of Sanity ow

    2/19/26 6:00:00 AM ET
    $BTI
    $OGI
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Canopy Growth Announces MTL Cannabis Shareholder Approval of Acquisition

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) is pleased to announce that shareholders of MTL Cannabis Corp. ("MTL Cannabis" or "MTL") have voted to approve the Company's previously announced acquisition of MTL (the "Transaction") at a special meeting of shareholders of MTL (the "MTL Shareholders") held February 17, 2026. The plan of arrangement with Canopy Growth received overwhelming support from MTL Shareholders, with (i) 99.97% of all shares of MTL (the "MTL Shares") cast in favour of the special resolution approving the Transaction, and (ii) 99.80% of MTL Shares, excluding votes attached to MTL Shares required to be excluded pursuant to Multilat

    2/18/26 7:56:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $CGC
    $CRON
    $ESE
    $NEPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity initiated coverage on Cronos Group

    Canaccord Genuity initiated coverage of Cronos Group with a rating of Buy

    1/27/26 9:29:20 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Canopy Growth upgraded by The Benchmark Company

    The Benchmark Company upgraded Canopy Growth from Sell to Hold

    11/10/25 8:33:16 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $CGC
    $CRON
    $ESE
    $NEPT
    Financials

    Live finance-specific insights

    View All

    Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026

    TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be arch

    2/12/26 7:30:00 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Organigram Reports First Quarter Fiscal 2026 Results

    Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2

    2/10/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ESCO Reports First Quarter Fiscal 2026 Results

    St. Louis, Feb. 05, 2026 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE:ESE) (ESCO, or the Company) today reported its operating results for the first quarter ended December 31, 2025 (Q1 2026).     Operating Highlights Q1 2026 Sales increased $75 million (35.0 percent) to $290 million compared to $215 million in Q1 2025. Q1 2026 organic sales increased $24 million (11.4 percent) and Maritime contributed $51 million (23.6 percent) of revenue growth in the quarter.Q1 2026 GAAP EPS from Continuing Operations increased 40.5 percent to $1.11 per share compared to $0.79 per share in Q1 2025. Q1 2026 Adjusted EPS from Continuing Operations increased 72.6 percent to $1.64 per share compared to

    2/5/26 4:15:00 PM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    $CGC
    $CRON
    $ESE
    $NEPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by ESCO Technologies Inc.

    SC 13G/A - ESCO TECHNOLOGIES INC (0000866706) (Subject)

    11/14/24 1:28:29 PM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    9/3/24 9:30:26 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CGC
    $CRON
    $ESE
    $NEPT
    Leadership Updates

    Live Leadership Updates

    View All

    Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada's Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand

    This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Highly accretive business combination expected to generate significant run-rate synergies of approximately $10 million within 18 months Strengthens Canopy Growth's presence in Québec with an opportunity to expand national distribution of MTL's high-quality, budtender-recommended product portfolio2 MTL's core management team is expected to join Canopy Growth to drive cultivation excellence and enhance the Company's p

    12/15/25 7:00:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Organigram Announces Appointment of Chief Executive Officer

    Organigram Global Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce that James Yamanaka, formerly Global Head of Strategy for British American Tobacco, has been appointed the Company's new Chief Executive Officer (CEO). Mr. Yamanaka is expected to assume the role effective on or about January 15, 2026. Mr. Yamanaka will also join the Company's board of directors when he assumes the role of Chief Executive Officer. Mr. Yamanaka is a seasoned executive, having spent more than 20 years at British American Tobacco, with extensive experience in strategy and general management across

    11/25/25 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canopy Growth Announces Results of Annual General and Special Meeting of Shareholders

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, is pleased to announce today the voting results from its Annual General and Special Meeting of Shareholders convened on September 26, 2025 and adjourned to, and reconvened on, October 10, 2025 (the "Meeting"). All of the matters put forward before the Company's shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated August 7, 2025 (the "Proxy Statement"), were approved by the requisite number of votes cast at the Meeting, as further detailed below. Each of t

    10/14/25 7:00:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care